See more : Apaq Technology Co., Ltd. (6449.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Global Partners LP (GLP) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Global Partners LP, a leading company in the Oil & Gas Midstream industry within the Energy sector.
- WisdomTree Energy Enhanced (XMWK.DE) Income Statement Analysis – Financial Results
- HarborOne Bancorp, Inc. (HONE) Income Statement Analysis – Financial Results
- Humedix Co., Ltd. (200670.KQ) Income Statement Analysis – Financial Results
- Xiamen Overseas Chinese Electronic Co.,Ltd. (600870.SS) Income Statement Analysis – Financial Results
- Lineage Cell Therapeutics, Inc. (LCTX.TA) Income Statement Analysis – Financial Results
Global Partners LP (GLP)
About Global Partners LP
Global Partners LP engages in the purchasing, selling, gathering, blending, storing, and logistics of transporting gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, and propane to wholesalers, retailers, and commercial customers in the New England states, Mid-Atlantic region, and New York. The company is also involved in the transportation of petroleum products and renewable fuels through rail from the mid-continent region of the United States and Canada. Its Wholesale segment sells home heating oil, branded and unbranded gasoline and gasoline blendstocks, diesel, kerosene, residual oil, and propane to home heating oil retailers and wholesale distributors. It also aggregates crude oil through truck or pipeline in the mid-continent region of the United States and Canada, as well as transports it through rail and ships it through barge to refiners. The company's Gasoline Distribution and Station Operations segment sells branded and unbranded gasoline to gasoline station operators and sub-jobbers; operates gasoline stations and convenience stores; and provides car wash, lottery, and ATM services, as well as leases gasoline stations. Its Commercial segment sells and delivers unbranded gasoline, home heating oil, diesel, kerosene, residual oil, and bunker fuel to customers in the public sector, as well as to commercial and industrial end-users; and sells custom blended fuels. As of December 31, 2021, the company had a portfolio of 1,595 owned, leased, and supplied gasoline stations, which included 295 directly operated convenience stores; and owned, leased, or maintained storage facilities at 26 bulk terminals with a collective storage capacity of 11.9 million barrels. Global GP LLC serves as the general partner of the company. The company was incorporated in 2005 and is based in Waltham, Massachusetts.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 16.49B | 18.88B | 13.25B | 8.32B | 13.08B | 12.67B | 8.92B | 8.24B | 10.31B | 17.27B | 19.59B | 17.63B | 14.84B | 7.80B | 5.82B | 9.02B | 6.76B | 4.47B | 1.25B | 3.19B | 2.48B | 1.59B | 1.75B |
Cost of Revenue | 15.98B | 17.78B | 12.53B | 7.60B | 12.42B | 12.02B | 8.34B | 7.69B | 9.72B | 16.73B | 19.18B | 17.29B | 14.63B | 7.63B | 5.67B | 8.90B | 6.63B | 4.36B | 1.22B | 3.11B | 2.41B | 1.54B | 1.69B |
Gross Profit | 513.83M | 1.10B | 719.26M | 721.14M | 662.76M | 650.41M | 583.05M | 546.49M | 597.67M | 542.61M | 405.83M | 333.49M | 209.60M | 166.72M | 149.83M | 119.79M | 126.98M | 113.23M | 28.91M | 75.87M | 67.10M | 55.20M | 62.50M |
Gross Profit Ratio | 3.12% | 5.81% | 5.43% | 8.67% | 5.07% | 5.13% | 6.54% | 6.63% | 5.79% | 3.14% | 2.07% | 1.89% | 1.41% | 2.14% | 2.58% | 1.33% | 1.88% | 2.53% | 2.31% | 2.38% | 2.71% | 3.46% | 3.56% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 273.73M | 263.11M | 212.88M | 192.53M | 170.94M | 171.00M | 155.03M | 149.67M | 177.04M | 153.96M | 115.49M | 101.46M | 152.14M | 113.84M | 96.09M | 73.85M | 73.24M | 65.19M | 15.44M | 53.04M | 30.30M | 27.50M | 26.80M |
Other Expenses | 0.00 | 454.12M | 364.29M | 334.14M | 353.81M | 279.45M | 309.05M | 297.94M | 303.81M | 222.94M | 204.93M | 147.44M | 4.80M | 3.53M | 2.99M | 2.88M | 2.25M | 1.53M | 390.00K | 4.79M | 18.80M | 17.70M | 0.00 |
Operating Expenses | 266.33M | 717.23M | 577.17M | 526.67M | 524.75M | 450.45M | 464.08M | 447.61M | 480.85M | 376.90M | 320.42M | 248.90M | 156.94M | 117.37M | 99.08M | 76.73M | 75.49M | 66.71M | 15.83M | 57.82M | 49.10M | 45.20M | 26.80M |
Cost & Expenses | 16.25B | 18.50B | 13.11B | 8.13B | 12.94B | 12.47B | 8.80B | 8.14B | 10.20B | 17.10B | 19.50B | 17.54B | 14.78B | 7.75B | 5.77B | 8.98B | 6.71B | 4.43B | 1.24B | 3.17B | 2.46B | 1.58B | 1.72B |
Interest Income | 0.00 | 81.26M | 80.09M | 83.54M | 89.86M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 85.63M | 81.26M | 80.09M | 83.54M | 89.86M | 89.15M | 86.23M | 86.32M | 73.33M | 47.76M | 43.54M | 36.27M | 31.21M | 22.31M | 15.19M | 20.80M | 17.41M | 11.90M | 2.69M | 4.70M | 2.00M | 2.20M | 3.00M |
Depreciation & Amortization | 110.09M | 104.80M | 102.24M | 100.14M | 108.19M | 106.84M | 105.65M | 111.94M | 13.50M | 18.87M | 19.22M | 45.46M | 30.36M | 20.08M | 2.99M | 15.13M | 9.61M | 4.11M | 953.00K | 3.23M | 0.00 | -1.10M | 26.07M |
EBITDA | 356.36M | 565.08M | 244.46M | 285.24M | 234.32M | 304.01M | 225.44M | -42.11M | 114.72M | 252.07M | 161.27M | 130.05M | 85.71M | 69.43M | 53.74M | 43.01M | 51.49M | 46.51M | 14.03M | 21.28M | 18.00M | 8.90M | 35.70M |
EBITDA Ratio | 2.16% | 2.06% | 1.15% | 2.47% | 1.14% | 1.66% | 1.44% | 1.31% | 1.26% | 1.07% | 0.53% | 0.74% | 0.56% | 0.89% | 0.92% | 0.65% | 0.70% | 1.12% | 1.12% | 0.67% | 0.73% | 0.56% | 2.04% |
Operating Income | 243.77M | 460.29M | 142.22M | 192.27M | 139.21M | 197.17M | 119.78M | -152.25M | 114.72M | 165.71M | 85.41M | 84.59M | 50.63M | 49.35M | 50.75M | 43.07M | 51.49M | 46.51M | 13.08M | 18.05M | 18.00M | 10.00M | 19.90M |
Operating Income Ratio | 1.48% | 2.44% | 1.07% | 2.31% | 1.06% | 1.56% | 1.34% | -1.85% | 1.11% | 0.96% | 0.44% | 0.48% | 0.34% | 0.63% | 0.87% | 0.48% | 0.76% | 1.04% | 1.05% | 0.57% | 0.73% | 0.63% | 1.13% |
Total Other Income/Expenses | -83.13M | -81.26M | -80.09M | -90.70M | -102.94M | -89.15M | -86.23M | -86.32M | -73.33M | -47.76M | -43.54M | -36.27M | -31.21M | -22.31M | -15.19M | -20.80M | -3.29M | -11.39M | 6.01M | 0.00 | -2.00M | -4.00M | 700.00K |
Income Before Tax | 160.64M | 379.03M | 62.13M | 101.56M | 36.27M | 108.03M | 33.55M | -238.57M | 41.39M | 117.94M | 41.87M | 48.32M | 19.42M | 27.04M | 35.56M | 22.21M | 48.20M | 35.13M | 10.39M | 0.00 | 16.00M | 6.00M | 20.60M |
Income Before Tax Ratio | 0.97% | 2.01% | 0.47% | 1.22% | 0.28% | 0.85% | 0.38% | -2.90% | 0.40% | 0.68% | 0.21% | 0.27% | 0.13% | 0.35% | 0.61% | 0.25% | 0.71% | 0.79% | 0.83% | 0.00% | 0.65% | 0.38% | 1.17% |
Income Tax Expense | 8.14M | 16.82M | 1.34M | -119.00K | 1.09M | 5.62M | -23.56M | 53.00K | -1.87M | 963.00K | 819.00K | 1.58M | 68.00K | 0.00 | 1.43M | 1.15M | 1.19M | 1.67M | 986.00K | 739.54K | 0.00 | 5.10M | -10.27M |
Net Income | 152.51M | 362.21M | 60.80M | 102.21M | 35.87M | 103.91M | 58.75M | -199.41M | 43.56M | 114.71M | 42.62M | 46.74M | 19.35M | 27.04M | 33.34M | 21.06M | 47.01M | 33.46M | 9.41M | 17.31M | 16.00M | 6.00M | 20.60M |
Net Income Ratio | 0.92% | 1.92% | 0.46% | 1.23% | 0.27% | 0.82% | 0.66% | -2.42% | 0.42% | 0.66% | 0.22% | 0.27% | 0.13% | 0.35% | 0.57% | 0.23% | 0.70% | 0.75% | 0.75% | 0.54% | 0.65% | 0.38% | 1.17% |
EPS | 3.77 | 10.06 | 1.79 | 2.77 | 0.82 | 3.08 | 1.74 | -5.95 | 1.12 | 3.97 | 1.43 | 1.73 | 0.88 | 1.61 | 2.56 | 1.57 | 1.38 | 2.46 | 1.60 | 3.07 | 2.84 | 1.06 | 3.65 |
EPS Diluted | 3.76 | 10.02 | 1.77 | 2.74 | 0.81 | 3.06 | 1.74 | -5.95 | 1.11 | 3.95 | 1.42 | 1.71 | 0.87 | 1.59 | 2.51 | 1.57 | 1.38 | 2.46 | 1.60 | 3.07 | 2.84 | 1.06 | 3.65 |
Weighted Avg Shares Out | 33.97M | 33.94M | 33.94M | 33.91M | 33.81M | 33.70M | 33.59M | 33.52M | 32.18M | 27.42M | 27.33M | 26.39M | 21.28M | 16.35M | 13.02M | 13.07M | 12.44M | 11.29M | 5.64M | 5.64M | 5.64M | 5.64M | 5.64M |
Weighted Avg Shares Out (Dil) | 34.04M | 34.04M | 34.28M | 34.31M | 34.34M | 33.97M | 33.63M | 33.53M | 32.32M | 27.50M | 27.56M | 26.57M | 21.47M | 16.60M | 13.28M | 13.07M | 12.44M | 11.29M | 5.64M | 5.64M | 5.64M | 5.64M | 5.64M |
Hims & Hers shares rally on results, but execs say GLP-1 drug shortage ‘is not abating'
Fractyl Health to Present New Preclinical Data on Sustained Weight Maintenance and Blood Sugar from its Rejuva® RJVA-001 Single-Administration GLP-1 Pancreatic Gene Therapy Candidate at ObesityWeek® 2024
Global Partners LP Completes Acquisition of East Providence Liquid Energy Terminal
Biomea Fusion Presents Preclinical Data Showing Icovamenib (BMF-219) Enhanced Effectiveness of GLP-1-Based Therapies and Introduces BMF-650, a Next-Generation, Oral Small-Molecule GLP-1 Receptor Agonist Candidate
Could Buying This Weight Loss Stock Be Like Investing in Novo Nordisk At The Dawn of The GLP-1 Revolution?
Madrigal: Why I'm Having Doubts On The Bull Case Ahead Of Q3 Earnings
Positive Partial 12-Week Blood Sugar Results from Lexaria's GLP-1 Diabetes Animal Study
Global Partners LP to Host Third-Quarter 2024 Financial Results Conference Call on November 8, 2024
Global Partners Declares Third-Quarter 2024 Cash Distribution of $0.7300 on Common Units
Structure Therapeutics: Potential To Have Best-In-Class GLP-1 Agonist For Obesity Patients
Source: https://incomestatements.info
Category: Stock Reports